What is Autoimmune Hemolytic Anemia / Cold Agglutinin Disease

Autoimmune Hemolytic Anemia (AIHA) associated with Cold Agglutinin Disease (CAD) is a rare type of autoimmune disorder where the immune system mistakenly attacks and destroys red blood cells when a person is exposed to cold temperatures. This condition leads to anemia and related symptoms because the body cannot replace these destroyed red blood cells fast enough to meet its oxygen-carrying needs.

What is Cold Agglutinin Disease and how does it affect the body?

Cold Agglutinin Disease is a specific form of autoimmune hemolytic anemia where cold-sensitive antibodies, known as cold agglutinins, bind to red blood cells at low temperatures (typically between 3°C and 4°C). This binding causes red blood cells to clump together (agglutinate) and triggers the body's complement system to destroy them, a process called hemolysis. This primarily affects the circulatory system, often leading to fatigue, shortness of breath, and acrocyanosis—a bluish discoloration of the hands, feet, ears, or nose upon cold exposure. At DiseaseMaps.org, 110 people with Autoimmune Hemolytic Anemia / Cold Agglutinin Disease have joined our community to share their experiences and navigate these challenges together.

What are the primary subtypes of this condition?

Clinicians generally categorize this condition into two distinct forms based on the underlying cause:

• Primary Cold Agglutinin Disease: This is a chronic, clonal lymphoproliferative disorder of the bone marrow. It is considered a rare, distinct disease entity not triggered by an underlying infection or cancer.


• Secondary Cold Agglutinin Syndrome: This form occurs as a result of an underlying condition, such as a viral infection (e.g., Mycoplasma pneumoniae or Epstein-Barr virus), autoimmune diseases, or certain types of lymphoma.

Who is typically affected by Cold Agglutinin Disease?

Cold Agglutinin Disease is rare, with an estimated prevalence of approximately 1 in 1,000,000 people per year. It is most frequently diagnosed in older adults, typically between the ages of 60 and 80. While it can affect anyone, research suggests a slight female predominance. Because it is an acquired condition rather than a hereditary one, there is no known genetic predisposition that parents pass to their children.

How does this differ from other forms of anemia?

Unlike iron-deficiency anemia, which is caused by a lack of nutrients, or other forms of autoimmune hemolytic anemia (such as Warm AIHA), Autoimmune Hemolytic Anemia / Cold Agglutinin Disease is uniquely defined by its temperature-dependent mechanism. Key differentiators include:

• Temperature sensitivity: Symptoms fluctuate significantly with ambient temperature changes.


• Direct Antiglobulin Test (DAT): In Cold Agglutinin Disease, this test is typically positive for complement (C3d) but negative for IgG, which helps distinguish it from "warm" antibody-mediated anemias.


• Clumping: The presence of red blood cell agglutination can sometimes interfere with automated blood count machines, leading to falsely high mean corpuscular volume (MCV) readings.

Next steps

• Consult a hematologist who specializes in rare blood disorders to confirm your diagnosis through specific serological testing.


• Prioritize "cold avoidance" strategies, such as dressing in layers and avoiding direct contact with cold items, to manage active symptoms.


• Join the Autoimmune Hemolytic Anemia / Cold Agglutinin Disease community at DiseaseMaps.org to connect with others who understand the day-to-day impact of this condition.


• Ask your physician about clinical trials if standard treatments are not providing adequate symptom relief.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cold Agglutinin Disease


• Orphanet: Cold Agglutinin Disease (ORPHA:99920)


• OMIM (Online Mendelian Inheritance in Man): Cold Agglutinin Disease entry


• Blood Journal: "Cold agglutinin disease: from pathophysiology to novel therapies"